PMID: 11898004Mar 19, 2002Paper

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis

The Journal of Allergy and Clinical Immunology
Sakari ReitamoEuropean /Canadian Tacrolimus Ointment Study Group

Abstract

Vehicle-controlled studies have demonstrated the efficacy and safety of tacrolimus ointment in the treatment of patients with atopic dermatitis (AD). This study was undertaken to compare 0.03% and 0.1% tacrolimus ointment with 1% hydrocortisone acetate ointment in children 2 to 15 years of age with moderate-to-severe AD. Treatment was twice daily to affected areas for 3 weeks in this multicenter, randomized, double-blind, parallel-group study. The primary endpoint was the modified eczema area and severity index (mEASI) mean area under the curve (mAUC) as a percentage of baseline. Five hundred sixty patients were randomized and received at least one application of ointment. Discontinuations included 21 of 189 patients from the 0.03% tacrolimus group, 13 of 186 patients from the 0.1% tacrolimus group, and 20 of 185 patients from the hydrocortisone acetate group. The median mEASI mAUC as a percentage of baseline showed 0.03% and 0.1% tacrolimus to be significantly more effective than 1% hydrocortisone acetate (P <.001) and 0.1% tacrolimus to be more effective than 0.03% tacrolimus (P =.006). The mEASI mAUC as a percentage of baseline was 44.8%, 39.8%, and 64.0% for patients who received 0.03% tacrolimus, 0.1% tacrolimus, and 1% hy...Continue Reading

Citations

Jun 29, 2002·BMJ : British Medical Journal·Hywel Williams
Mar 25, 2008·Therapeutics and Clinical Risk Management·Sonja StänderElke Weisshaar
Jan 1, 2008·Patient Preference and Adherence·Christina M Gelbard, Adelaide A Hebert
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Antonello BaldoLuisa Di Costanzo
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Masutaka Furue, Satoshi Takeuchi
Jan 1, 2010·Clinical, Cosmetic and Investigational Dermatology·Hobart W Walling, Brian L Swick
Nov 25, 2003·Southern Medical Journal·Angela AhujaCheryl J Barnes
Jun 25, 2005·American Journal of Respiratory and Critical Care Medicine·Mariëlle W PijnenburgJohan C De Jongste
Sep 15, 2007·The British Journal of Dermatology·M H A Rustin
Sep 11, 2008·The British Journal of Dermatology·D ThaçiUNKNOWN European Tacrolimus Ointment Study Group
May 14, 2009·Expert Opinion on Drug Safety·Anita Remitz, Sakari Reitamo
Jul 1, 2009·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·N DossY de Prost
Jun 6, 2009·American Journal of Clinical Dermatology·John R IngramAndrew Y Finlay
Jan 1, 2005·Journal of Cutaneous Medicine and Surgery·Charles LyndeNeil Shear
Aug 4, 2010·Pediatric Dermatology·Alexandra D McCollumLawrence F Eichenfield
May 14, 2011·Current Medical Research and Opinion·A SvenssonS A Mitchell
May 4, 2013·The Journal of Dermatological Treatment·Haydar UcakNurhan Halisdemir
May 20, 2015·Dermatitis : Contact, Atopic, Occupational, Drug·Brian Keng Yong Chia, Hong Liang Tey
Dec 30, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas WerfelUNKNOWN Association of Scientific Medical Societies of Germany
Aug 23, 2016·The British Journal of Dermatology·H NankervisH C Williams
Jan 27, 2019·Dermatology and Therapy·Zoe D DraelosSheryl Baldwin
Sep 4, 2019·Journal of Cutaneous Medicine and Surgery·Loretta FiorilloMichele Ramien
Apr 30, 2003·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S Ständer, T A Luger
Apr 30, 2003·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·D Thaçi
Sep 28, 2002·Current Opinion in Pediatrics·Kelly D Stone
May 7, 2003·Hospital Medicine·Malcolm Rustin
Aug 11, 2004·American Journal of Clinical Dermatology·Michael IskedjianThomas R Einarson
Dec 2, 2004·Pediatric Emergency Care·Joseph D Losek
Apr 1, 2005·American Journal of Clinical Dermatology·Kristine BreuerAlexander Kapp
Sep 8, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·U DarsowUNKNOWN European Task Force on Atopic Dermatitis/EADV Eczema Task Force
May 4, 2006·Dermatologic Therapy·Masutaka FurueKazunori Urabe
Dec 1, 2011·International Journal of Dermatology·Kyu-Han Kim, Takeshi Kono
Sep 20, 2011·International Journal of Dermatology·Johanna M MandelinNasrullah Undre
Jul 16, 2010·The Annals of Pharmacotherapy·Antonia CarboneRupal Patel
Mar 24, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·A WollenbergUNKNOWN European Task Force on Atopic Dermatitis/EADV Eczema Task Force
Apr 21, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A WollenbergUNKNOWN European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allerg
Oct 6, 2004·Expert Opinion on Pharmacotherapy·Christie L Carroll, Alan B Fleischer
Nov 19, 2004·The British Journal of Dermatology·A AlomarUNKNOWN European Working Group on Atopic Dermatitis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.